Safety and Efficacy of Tranexamic Acid Compared With Aprotinin in Thoracic Aortic Surgery With Deep Hypothermic Circulatory Arrest

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 24, Issue 1, 2010, Pages 73-79

  Nicolau Raducu, Ramona ^a   Subramaniam, Kathirvel ^b   Marquez, Jose ^b   Wells, Cynthia ^b   Hilmi, Ibtesam ^b   Sullivan, Erin ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

aprotinin; deep hypothermic circulatory arrest; thoracic aortic surgery; tranexamic acid

Indexed keywords

APROTININ; CREATININE; TRANEXAMIC ACID;

ADULT; ARTICLE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; COHORT ANALYSIS; COMORBIDITY; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DEEP HYPOTHERMIC CIRCULATORY ARREST; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HEART DISEASE; HUMAN; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; LENGTH OF STAY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEUROLOGICAL COMPLICATION; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SURGICAL MORTALITY; SURVIVAL; THORACIC AORTA SURGERY;

ANTIFIBRINOLYTIC AGENTS; AORTIC DISEASES; APROTININ; BLOOD TRANSFUSION; CIRCULATORY ARREST, DEEP HYPOTHERMIA INDUCED; COHORT STUDIES; CREATININE; FEMALE; HEMOSTATICS; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 74449089109     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2009.06.010     Document Type: Article

References (29)

1. Umscheid C.A., Kohl B.A., and Williams K. Antifibrinolytic use in adult cardiac surgery. Curr Opin Hematol 14 (2007) 455-467
2. Mangano D.T., Tudor I.C., Dietzel C., Multicenter Study of Perioperative Ischemia Research Group, and Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
3. Fergusson D.A., Hebert P.C., Mazer C.D., et al. (BART study). A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358 (2008) 2319-2331
4. Chukwuemeka A., Weisel A., Mangani M., et al. Renal dysfunction in high-risk patients after on-pump and off-pump coronary artery bypass surgery: A propensity score analysis. Ann Thorac Surg 80 (2005) 2148-2154
5. Mehta R.L., Kellum J.A., Shah S.V., et al. Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 11 (2007) R31
6. Kellum J.A., Mehta R.L., Angus D.C., et al. The first international consensus conference on continuous renal replacement therapy. Kidney Int 62 (2002) 1855-1863
7. Mossad E.B., Machado S., and Apostolakis J. Bleeding following deep hypothermia and circulatory arrest in children. Semin Cardiothorac Vasc Anesth 11 (2007) 34-46
8. Krause K.R., Howells G.A., Buhs C.L., et al. Hypothermia-induced coagulopathy during hemorrhagic shock. Am Surg 66 (2000) 348-354
9. Kirkpatrick A.W., Chun R., Brown R., et al. Hypothermia and the trauma patient. Can J Surg 42 (1999) 333-343
10. Westaby S. Coagulation disturbance in profound hypothermia: The influence of anti-fibrinolytic therapy. Semin Thorac Cardiovasc Surg 9 (1997) 246-256
11. Wilde J.T. Hematological consequences of profound hypothermic circulatory arrest and aortic dissection. J Card Surg 12 suppl (1997) 201-206
12. Westaby S. Anti-fibrinolytic therapy in thoracic aortic surgery. Ann Thorac Surg 67 (1999) 1983-1985
13. Stundt T.M., Kouchoukos N.T., Saffitz J.E., et al. Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest. Ann Thorac Surg 55 (1993) 1418-1424
14. Westaby S., Forni A., Dunning J., et al. Aprotinin and bleeding in profoundly hypothermic perfusion. Eur J Cardiothorac Surg 8 (1994) 82-86
15. Parolari A., Antona C., Alamanni F., et al. Aprotinin and deep hypothermic circulatory arrest: There are no benefits even when appropriate amounts of heparin are given. Eur J Cardiothorac Surg 11 (1997) 149-156
16. Goldstein D.J., DeRosa C.M., Mongero L.B., et al. Safety and efficacy of aprotinin under conditions of deep hypothermia and circulatory arrest. J Thorac Cardiovasc Surg 110 (1995) 1615-1622
17. Seigne P.W., Shorten G.D., Johnson R.G., et al. The effects of aprotinin on blood product transfusion associated with thoracic aortic surgery requiring deep hypothermic circulatory arrest. J Cardiothorac Vasc Anesth 14 (2000) 676-681
18. Ehrlich M., Grabenwöger M., Cartes-Zumelzu F., et al. Operations on the thoracic aorta and hypothermic circulatory arrest: Is aprotinin safe?. J Thorac Cardiovasc Surg 115 (1998) 220-225
19. Mora Mangano C.T., Neville M.J., Hsu P.H., et al. Aprotinin, blood loss, and renal dysfunction in deep hypothermic circulatory arrest. Circulation 104 suppl 1 (2001) I276-I281
20. Casati V., Sandreli L., Speziali G., et al. Hemostatic effects of tranexamic acid in elective thoracic aortic surgery: A prospective, randomized, double-blind, placebo-controlled study. J Thorac Cardiovasc Surg 123 (2002) 1084-1091
21. Shimamura Y., Nakajima M., Hirayama T., et al. The effect of intraoperative high-dose tranexamic acid on blood loss after operation for acute aortic dissection. J Thorac Cardiovasc Surg 46 (1998) 616-621
22. Eaton M.P., and Deeb G.M. Aprotinin versus epsilon-aminocaproic acid for aortic surgery using deep hypothermic circulatory arrest. J Cardiothorac Vasc Anesth 12 (1998) 548-552
23. Wong B.I., McLean R.F., Fremes S.E., et al. Aprotinin and tranexamic acid for high transfusion risk cardiac surgery. Ann Thorac Surg 69 (2000) 808-816
24. Karkouti K., Beattie W.S., Dattilo K.M., et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 46 (2006) 327-338
25. Shaw A.D., Stafford-Smith M., White W.D., et al. The effects of aprotinin on outcome after coronary-artery bypass grafting. N Engl J Med 358 (2008) 784-793
26. Schneeweiss S., Seeger J.D., Landon J., et al. Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med 358 (2008) 771-783
27. Dowd N.P., Karski J.M., Cheng D.C., et al. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology 2 (2002) 390-399
28. O'Connell K.A., Wood J.J., Wise R.P., et al. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 295 (2006) 293-298
29. Tripepe L., De Santis V., Vitale D., et al. Recombinant activated factor VII for refractory bleeding after acute aortic dissection surgery: A propensity score analysis. Crit Care Med 35 (2007) 1685-1690